Leonard Buckbinder is the founder of Scorpion Therapeutics. Scorpion Therapeutics has raised $515M in total funding. Latest round: Series D.
Leonard Buckbinder is the Co-founder and Chief Scientific Officer (CSO) of Scorpion Therapeutics, a Boston-based biotechnology company. He previously held leadership roles in oncology at GlaxoSmithKline before co-founding Scorpion in 2021. He is the corresponding author on research for Scorpion's lead drug candidate, STX-478.
Full founder directory · Investor directory · Company funding database · Fundraising library